JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4626
Quad
QUAD
$486M
| $301K | ﹤0.01% |
109,522
-16,439
| -13% | -$79.5K |
2013 Q2
36 quarters
|
|
4627
The ONE Group
STKS
$52.3M
| $301K | ﹤0.01% |
40,853
-21,018
| -34% | -$192K |
2021 Q2
4 quarters
|
|
|
STER
4628
DELISTED
Sterling Check Corp. Common Stock
STER
| $301K | ﹤0.01% |
18,494
+6,666
| +56% | +$142K |
2021 Q3
3 quarters
|
|
|
ESMT
4629
DELISTED
EngageSmart, Inc.
ESMT
| $301K | ﹤0.01% |
18,741
+11,217
| +149% | +$223K |
2021 Q4
2 quarters
|
|
4630
PUT
B&G Foods
BGS
$236M
| $300K | ﹤0.01% |
12,600
| – | – |
2022 Q1
1 quarter
|
|
4631
POET Technologies
POET
$1.4B
| $300K | ﹤0.01% |
30,660
+14,400
| +89% | +$85.5K |
2022 Q1
1 quarter
|
|
|
GTYH
4632
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $300K | ﹤0.01% |
47,786
+32,570
| +214% | +$166K |
2019 Q2
12 quarters
|
|
4633
Compugen
CGEN
$225M
| $299K | ﹤0.01% |
161,385
-135,725
| -46% | -$293K |
2020 Q2
8 quarters
|
|
4634
Transportadora de Gas del Sur
TGS
$3.74B
| $299K | ﹤0.01% |
58,226
+18,037
| +45% | +$114K |
2021 Q1
5 quarters
|
|
4635
Artesian Resources
ARTNA
$347M
| $298K | ﹤0.01% |
6,068
+1,830
| +43% | +$86K |
2013 Q2
36 quarters
|
|
4636
iShares MSCI Poland ETF
EPOL
$801M
| $298K | ﹤0.01% |
20,370
+19,563
| +2,424% | +$316K |
2021 Q4
2 quarters
|
|
4637
Stoke Therapeutics
STOK
$1.68B
| $297K | ﹤0.01% |
22,498
+2,890
| +15% | +$43.9K |
2019 Q3
11 quarters
|
|
4638
CALL
Regeneron Pharmaceuticals
REGN
$75.8B
| $296K | ﹤0.01% |
500
| – | – |
2022 Q1
1 quarter
|
|
4639
Wheels Up
UP
$122M
| $296K | ﹤0.01% |
759
+508
| +202% | +$271K |
2021 Q3
3 quarters
|
|
|
DAWN
4640
DELISTED
Day One Biopharmaceuticals
DAWN
| $295K | ﹤0.01% |
16,515
-4,436
| -21% | -$45.8K |
2021 Q2
4 quarters
|
|
4641
PennantPark Floating Rate Capital
PFLT
$687M
| $295K | ﹤0.01% |
25,669
-10,486
| -29% | -$130K |
2013 Q2
36 quarters
|
|
4642
Schwab US Large- Cap ETF
SCHX
$74.8B
| $295K | ﹤0.01% |
19,761
-1,473
| -7% | -$23.9K |
2018 Q3
15 quarters
|
|
4643
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$343M
| $295K | ﹤0.01% |
11,293
-2,052
| -15% | -$52.1K |
2018 Q4
14 quarters
|
|
|
IVC
4644
DELISTED
Invacare Corporation
IVC
| $295K | ﹤0.01% |
230,940
-215,790
| -48% | -$284K |
2016 Q1
25 quarters
|
|
|
CLR
4645
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $294K | ﹤0.01% |
+4,500
| New | +$285K |
2022 Q2
0 quarters
|
|
|
MLNK
4646
DELISTED
MeridianLink
MLNK
| $293K | ﹤0.01% |
17,580
+2,979
| +20% | +$51.2K |
2021 Q3
3 quarters
|
|
4647
PUT
Motorola Solutions
MSI
$74.1B
| $293K | ﹤0.01% |
1,400
| – | – |
2021 Q3
3 quarters
|
|
|
ORGN
4648
DELISTED
Origin Materials
ORGN
| $293K | ﹤0.01% |
1,912
+1,324
| +225% | +$252K |
2021 Q4
2 quarters
|
|
4649
Philips
PHG
$23.4B
| $293K | ﹤0.01% |
15,875
-49,202
| -76% | -$1.06M |
2013 Q2
36 quarters
|
|
4650
Silicom
SILC
$323M
| $293K | ﹤0.01% |
8,722
-3,792
| -30% | -$135K |
2019 Q3
11 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.